Neuropsychiatry, Royal Melbourne Hospital


Neuropsychiatry team portal:

Publications: Full list on PubMed

the Markers in Neuropsychiatric Disorders (MiND) study

The Seminars in Neuropsychiatry has moved to:


Click here for the full list of publications on PubMed (currently only first author displays below, unfortunately)

See more

Neuropsychiatry, Royal Melbourne Hospital:

Please click here to complete the Seminars in Neuropsychiatry survey

RMH-Alfred-Concord Seminars in Neuropsychiatry

Unfortunately due to COVID-19 and the rapidly evolving situation and impacts this has had at our main lecture sites, we have had to cancel/postpone the 13 April talk by Dr Chris Kyndt. We plan to resume on 12 May, but in a purely ‘virtual’ setting, with lectures delivered and attended via Zoom. Please do not hesitate to contact us if we can clarify anything. We hope you are managing as best as you can and looking after yourselves and others, during these challenging times.

Neuropsychiatry at the Royal Melbourne, Alfred and Concord Hospitals are pleased to have several seminars planned for 2020. Please spread the word to colleagues far and wide with this link:

To receive details on how to attend sessions, for any queries, feedback, to suggest potential future topics, and to be put on the email list, please contact us.

Save the dates for these upcoming seminars (Melbourne time):
8-9am (Melbourne time) on the following Tuesdays:

14 April: Dr Chris Kyndt: autoimmune encephalitis postponed to 1 December

12 May: Professor Perminder Sachdev: DSM-5 classification of neurocognitive disorders

14 July: A/Professor David Darby: cognitive assessment

1 September: TBC

13 October: Professor Julian Trollor: mental health and well-being of autistic adults

1 December: Dr Chris Kyndt: autoimmune encephalitis

Please click here to access slides and other materials from previous seminars.

Kind regards,
Dr Dhamidhu Eratne
Dr Toby Winton-Brown
Dr Andrew Gleason
Professor Dennis Velakoulis

Contact us


Thank you

We hope you’ve enjoyed our RMH-Alfred Neuropsychiatry Education Series this year, and we look forward to seeing you next year.

– Dhamidhu Eratne, Toby Winton-Brown, Dennis Velakoulis, and many others, on behalf of the Section of Neuropsychiatry and Royal Melbourne Hospital and the Alfred

Thank you to all our excellent speakers for their time, and special mention and thanks to Kate Egan, Nicholas Burgess, and Lily Ward for keeping the lecture series afloat.

Please keep in touch via and updated via

Now it’s feedback time!

Please go to this website to give us some (anonymous) feedback:

Genetics in Neurodegenerative Disorders Symposium

This research and clinically focussed event promises to offer a broad overview of current issues in genetics in neurodegenerative disorders, and should be of interest to a wide range of clinicians, researchers and scientists in the neurosciences.

Ticketing has been reopened!

Register now via this Eventbrite link:

Please contact Dr Dhamidhu Eratne ( if you have any queries.

Programme and Speakers:

Monday 12 August, 1400-1730
Venue TBC at MCRI/RCH – trying to get larger venue

1400-1500 Glenda Halliday (confirmed) – opening plenary – “Overview of neurodegenerative genetics and why NGS is needed”

1500-1520 (15min + 5min for questions) Dhamidhu Eratne (confirmed) – “WES, What is it Good for (in Neurodegenerative Disorders)? Updates from the Melbourne Genomics Complex Neurology Flagship” 

1520-1540 (15min + 5min for questions) Martin Delatycki and David Szmulewicz (confirmed) – “Genetic ataxia- what is the latest about aetiology and treatment?”

1540-1600Coffee break

1600-1620 (15min + 5min for questions) Aamira Huq (confirmed) – “The Paradox of the Young Demented and the Old Resilient – Can Genetics Explain?”

1620-1640 (15min + 5min for questions) Melanie Bahlo (confirmed) – “Repeat Expansion Detection from NGS Data for Neurodegenerative Disorders”

1640-1700 (15min + 5min for questions) Sam Berkovic (confirmed) – “Genetics in Epilepsy”

1700-1730 (20-25 + 5-10min for questions) Steve Petrou (confirmed) – “The Promise of Antisense Oligonucleotide Therapy in Neurogenetic Disorders”